Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors
Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a speci...
Saved in:
Published in | Scandinavian journal of immunology Vol. 95; no. 2; pp. e13124 - n/a |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.02.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a specialized set of membrane‐bound receptors known as Toll‐like receptors. Once this interaction is established, toll‐like receptor passes on the responsibility to cytosolic NOD‐like receptors through a cascade of signalling pathways. Subsequently, NOD‐like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase‐1 and Gasdermin‐D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase‐1 cleaves and activates pro‐inflammatory cytokines IL‐1β and IL‐18. On the other hand, Gasdermin‐D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors. |
---|---|
AbstractList | Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the 'danger signals' via a specialized set of membrane-bound receptors known as Toll-like receptors. Once this interaction is established, toll-like receptor passes on the responsibility to cytosolic NOD-like receptors through a cascade of signalling pathways. Subsequently, NOD-like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase-1 and Gasdermin-D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase-1 cleaves and activates pro-inflammatory cytokines IL-1β and IL-18. On the other hand, Gasdermin-D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors.Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the 'danger signals' via a specialized set of membrane-bound receptors known as Toll-like receptors. Once this interaction is established, toll-like receptor passes on the responsibility to cytosolic NOD-like receptors through a cascade of signalling pathways. Subsequently, NOD-like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase-1 and Gasdermin-D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase-1 cleaves and activates pro-inflammatory cytokines IL-1β and IL-18. On the other hand, Gasdermin-D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors. Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance the tissue insult, innate immunity is always at the forefront. Cells of innate immunity efficiently recognize the ‘danger signals’ via a specialized set of membrane‐bound receptors known as Toll‐like receptors. Once this interaction is established, toll‐like receptor passes on the responsibility to cytosolic NOD‐like receptors through a cascade of signalling pathways. Subsequently, NOD‐like receptors assemble to a specialized multiprotein intracellular complex, that is inflammasome. Inflammasome activates Caspase‐1 and Gasdermin‐D which initiate pyroptotic cell death in the affected tissue by two simultaneous mechanisms. Being a protease, caspase‐1 cleaves and activates pro‐inflammatory cytokines IL‐1β and IL‐18. On the other hand, Gasdermin‐D causes proteolytic cleavage which forms a pore in the cell membrane. This review highlights the molecular events ranging from recognition of stimuli to pyroptosis. The review is also an attempt to discuss the mechanisms of the most specific experimental NLRP3 inhibitors. |
Author | Kinra, Manas Nampoothiri, Madhavan Mudgal, Jayesh Arora, Devinder |
Author_xml | – sequence: 1 givenname: Manas surname: Kinra fullname: Kinra, Manas organization: Manipal Academy of Higher Education – sequence: 2 givenname: Madhavan surname: Nampoothiri fullname: Nampoothiri, Madhavan organization: Manipal Academy of Higher Education – sequence: 3 givenname: Devinder surname: Arora fullname: Arora, Devinder organization: Griffith University – sequence: 4 givenname: Jayesh orcidid: 0000-0001-8190-7031 surname: Mudgal fullname: Mudgal, Jayesh email: jayesh.mudgal@manipal.edu organization: Manipal Academy of Higher Education |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34861056$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1uEzEUhS1URNPAghdAltjQxbT-nZ8lqmhpFQEKZT3yzFwTR2N7sJ2m2fEIPCNPUrcpLCrB3dzNd47uPecIHTjvAKHXlJzQPKdxbU4op0w8QzPKS1lwUvMDNCOckKIRlTxERzGuCaGcVfwFOuSiLimR5QzdLuHGwNa47zitABs7-ZCU6wF7ja8Xy98_f31aLL_wvKdd8FPy0UQ8qbTaqh1WbsAW-pVyJtp7BdxOEIwFl9SIH4TYOD0qa1X0Nvu7lelM8iG-RM-1GiO8etxz9O38w_XZx2Lx-eLy7P2i6IUUoqhqoRWjSgrVlV3FlaQgGW204B0ZBBsqPSjasL4nVdNQQnQHjZaC1zXXFRn4HL3b-07B_9hATK01sYdxVA78JrasJGXDJCUso2-foGu_CS5flylGBBdlznWO3jxSm87C0E75XxV27Z9MM3C8B_rgYwyg_yKUtPd9tbmv9qGvzJ4-YXuTVDLepaDM-D_F1oyw-7d1-_Xqcq-4A-5up-A |
CitedBy_id | crossref_primary_10_1016_j_tcm_2022_05_001 crossref_primary_10_1016_j_phymed_2024_155859 crossref_primary_10_3389_fimmu_2023_1279264 crossref_primary_10_1016_j_jep_2024_118962 crossref_primary_10_1016_j_biopha_2023_115493 crossref_primary_10_1016_j_ygeno_2025_111033 crossref_primary_10_3390_ph16101455 crossref_primary_10_3390_ph17030402 crossref_primary_10_1007_s10753_024_02025_2 crossref_primary_10_1007_s00415_022_11491_3 crossref_primary_10_1016_j_tice_2023_102069 crossref_primary_10_1007_s12035_025_04779_8 crossref_primary_10_1038_s41401_023_01054_1 crossref_primary_10_3389_fphys_2024_1326392 crossref_primary_10_1007_s12035_023_03844_4 crossref_primary_10_1186_s40001_023_01564_y crossref_primary_10_1016_j_jri_2023_103992 crossref_primary_10_3390_cells11244111 crossref_primary_10_1016_j_ijbiomac_2024_129669 crossref_primary_10_1002_advs_202300824 crossref_primary_10_1007_s12015_023_10520_6 crossref_primary_10_1016_j_biopha_2024_116673 crossref_primary_10_3390_cells11203269 crossref_primary_10_1016_j_bioorg_2023_106362 crossref_primary_10_1007_s12035_023_03437_1 crossref_primary_10_1021_acsnano_3c01760 crossref_primary_10_3390_antiox11020269 crossref_primary_10_1038_s41467_024_46322_8 crossref_primary_10_1002_mco2_311 crossref_primary_10_1002_adtp_202400197 |
Cites_doi | 10.1038/nature09663 10.4049/jimmunol.1101284 10.1111/j.1600-065X.2012.01146.x 10.1038/cmi.2016.29 10.1074/jbc.M113.515080 10.1146/annurev.biochem.71.110601.135414 10.1097/FJC.0000000000000053 10.1038/nri3446 10.1111/febs.12283 10.1016/j.cell.2010.01.040 10.3389/fimmu.2019.02538 10.1186/s12974-019-1471-y 10.1189/jlb.3HI0814-371RR 10.1038/nm.3804 10.1016/j.cyto.2008.01.006 10.3389/fimmu.2014.00316 10.1016/j.immuni.2016.01.012 10.3390/molecules25235533 10.1038/nature11588 10.1002/eji.201545655 10.1111/j.1365-2567.2004.01976.x 10.4110/in.2018.18.e27 10.1152/advan.00058.2013 10.1038/nri2569 10.1146/annurev.biochem.74.082803.133347 10.1038/ni1253 10.1038/nature11729 10.1016/j.bcp.2013.03.008 10.1371/journal.ppat.1000559 10.1104/pp.110.161547 10.1016/j.bbabio.2009.06.004 10.1038/nm.3806 10.1074/jbc.M109.082305 10.1146/annurev.immunol.24.021605.090552 10.1042/BJ20121651 10.1038/nm.3893 10.1152/physrev.00009.2014 10.1007/s00251-020-01158-6 10.1074/jbc.RA118.003314 10.1038/ni.3333 10.1111/j.1365-2141.2009.07988.x 10.1126/science.1102218 10.1038/ni.2215 10.1038/nri2873 10.4049/jimmunol.0901363 10.1016/j.molcel.2012.11.009 10.1016/j.ejps.2020.105637 10.1084/jem.21213insight1 10.1083/jcb.200903124 10.1016/S1097-2765(00)80032-5 10.1074/jbc.R700009200 10.1093/intimm/dxp017 10.1186/s41232-018-0085-6 10.1016/j.immuni.2011.02.006 10.1038/nature16959 10.1007/s00702-017-1686-y 10.1016/j.autrev.2018.01.020 10.1074/jbc.C115.700492 10.1128/CMR.00046-08 10.1074/jbc.M112.381228 10.3109/08830185.2010.529976 10.1128/ecosalplus.ESP-0001-2018 10.1165/rcmb.2006-0323OC 10.1038/s41589-019-0277-7 10.3389/fimmu.2017.00036 10.1016/S1097-2765(02)00599-3 10.4049/jimmunol.179.6.4083 10.1016/j.mam.2020.100924 10.1074/jbc.M109.023044 10.1084/jem.20132486 10.3389/fphar.2015.00262 10.1189/jlb.0306164 10.1126/science.1087262 10.1007/978-3-7643-8550-7_35 10.1038/nrmicro2070 10.1371/journal.ppat.1005596 10.1016/B978-0-12-805417-8.00014-7 10.1097/FJC.0000000000000247 10.1038/nature15514 10.1038/cr.2010.135 10.1073/pnas.0611496104 10.1038/ni.2550 10.1165/rcmb.2011-0135OC 10.1006/bbrc.1997.7672 10.4049/jimmunol.1201644 10.3389/fimmu.2017.01518 10.1038/emm.2013.97 10.2131/jts.41.273 10.1152/ajpcell.00217.2006 10.1016/j.cell.2014.11.047 10.1084/jem.20171419 |
ContentType | Journal Article |
Copyright | 2021 The Scandinavian Foundation for Immunology. Copyright © 2022 The Scandinavian Foundation for Immunology |
Copyright_xml | – notice: 2021 The Scandinavian Foundation for Immunology. – notice: Copyright © 2022 The Scandinavian Foundation for Immunology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7U9 8FD FR3 H94 K9. M7N NAPCQ P64 7X8 |
DOI | 10.1111/sji.13124 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Virology and AIDS Abstracts Technology Research Database Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Chemoreception Abstracts Immunology Abstracts Engineering Research Database Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Nursing & Allied Health Premium MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1365-3083 |
EndPage | n/a |
ExternalDocumentID | 34861056 10_1111_sji_13124 SJI13124 |
Genre | reviewArticle Journal Article Review |
GrantInformation_xml | – fundername: Griffith University funderid: RG/0618111 – fundername: Council for Scientific and Industrial Research funderid: 08/602(0005)/19EMR‐I – fundername: Griffith University grantid: RG/0618111 – fundername: Council for Scientific and Industrial Research grantid: 08/602(0005)/19EMR-I |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHEFC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB AOETA ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FIJ FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IH2 IHE IPNFZ IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OBS OHT OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 Y6R YFH YOC YUY ZGI ZXP ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7U9 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 K9. M7N NAPCQ P64 7X8 |
ID | FETCH-LOGICAL-c4544-784fa21a54ab6b73a51e5219f43b0d42d7fda192cc0799100fbe9f543883f70d3 |
IEDL.DBID | DR2 |
ISSN | 0300-9475 1365-3083 |
IngestDate | Fri Jul 11 11:19:44 EDT 2025 Fri Jul 25 10:10:47 EDT 2025 Wed Feb 19 02:27:09 EST 2025 Tue Jul 01 03:57:01 EDT 2025 Thu Apr 24 22:51:35 EDT 2025 Wed Jan 22 16:27:40 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | NLRP3 inflammasome Pyroptosis inflammasome inhibitors |
Language | English |
License | 2021 The Scandinavian Foundation for Immunology. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4544-784fa21a54ab6b73a51e5219f43b0d42d7fda192cc0799100fbe9f543883f70d3 |
Notes | Funding information Authors would like to acknowledge Council of Scientific and Industrial Research (CSIR), Human Resource Development Group, Government of India for providing the research fellowship (08/602(0005)/19EMR‐I). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0001-8190-7031 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/sji.13124 |
PMID | 34861056 |
PQID | 2620434608 |
PQPubID | 37516 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2606925102 proquest_journals_2620434608 pubmed_primary_34861056 crossref_primary_10_1111_sji_13124 crossref_citationtrail_10_1111_sji_13124 wiley_primary_10_1111_sji_13124_SJI13124 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2022 |
PublicationDateYYYYMMDD | 2022-02-01 |
PublicationDate_xml | – month: 02 year: 2022 text: February 2022 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Scandinavian journal of immunology |
PublicationTitleAlternate | Scand J Immunol |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 25 2007; 104 2010; 10 2017; 8 2012; 287 2011; 117 2019; 10 2010; 148 2002; 10 2019; 15 2019; 16 2006; 291 2010; 140 2014; 63 2013; 280 2012; 13 2012; 249 2007; 36 2014; 211 2012; 492 2015; 45 2018; 8 2007; 179 2010; 20 2001; 299 2014; 5 2013; 14 2018; 293 2021; 157 2006; 24 2013; 13 2010; 154 2005; 74 2016; 41 2009; 284 2017; 124 2018; 38 2013; 190 2016; 44 2014; 289 2009; 22 2009; 1787 2015; 160 2015; 6 2009; 21 2013; 49 2007; 282 2015; 95 2013; 45 2015; 97 2019; 78 2013; 85 2011; 30 1996 2010; 285 2011; 34 2015; 526 2020; 76 2004; 306 2016; 17 2017; 214 2016; 12 2018; 18 2018; 17 2013; 37 2004; 113 2011; 469 2017; 14 1997; 240 2020; 72 2020 2015; 66 2015; 21 2009; 187 2016; 530 2009; 9 2018 2007; 81 2005; 6 2016 2009; 183 2009; 7 2013; 493 2002; 71 2015 2009; 5 1998; 1 2013; 451 2008; 42 2003; 301 2016; 291 2012; 46 2011; 187 e_1_2_9_75_1 e_1_2_9_98_1 e_1_2_9_52_1 e_1_2_9_79_1 e_1_2_9_94_1 e_1_2_9_10_1 e_1_2_9_56_1 e_1_2_9_33_1 e_1_2_9_90_1 e_1_2_9_71_1 e_1_2_9_14_1 e_1_2_9_37_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_64_1 e_1_2_9_87_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_68_1 e_1_2_9_83_1 e_1_2_9_6_1 e_1_2_9_60_1 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_30_1 e_1_2_9_99_1 e_1_2_9_72_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_95_1 e_1_2_9_76_1 e_1_2_9_91_1 Chuang YT (e_1_2_9_53_1) 2011; 117 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_88_1 e_1_2_9_61_1 e_1_2_9_46_1 e_1_2_9_84_1 e_1_2_9_23_1 e_1_2_9_65_1 e_1_2_9_80_1 e_1_2_9_5_1 e_1_2_9_9_1 e_1_2_9_27_1 e_1_2_9_69_1 e_1_2_9_31_1 e_1_2_9_50_1 e_1_2_9_73_1 e_1_2_9_35_1 e_1_2_9_77_1 e_1_2_9_96_1 e_1_2_9_12_1 e_1_2_9_54_1 e_1_2_9_92_1 e_1_2_9_101_1 e_1_2_9_39_1 Perregaux DG (e_1_2_9_93_1) 2001; 299 e_1_2_9_16_1 e_1_2_9_58_1 Janeway CA (e_1_2_9_2_1) 1996 e_1_2_9_20_1 e_1_2_9_62_1 e_1_2_9_89_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_66_1 e_1_2_9_85_1 e_1_2_9_8_1 e_1_2_9_81_1 e_1_2_9_4_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_74_1 e_1_2_9_51_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_97_1 e_1_2_9_70_1 e_1_2_9_100_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_59_1 e_1_2_9_63_1 e_1_2_9_40_1 e_1_2_9_21_1 e_1_2_9_67_1 e_1_2_9_44_1 e_1_2_9_86_1 e_1_2_9_7_1 Jansen T (e_1_2_9_78_1) 2019; 78 e_1_2_9_82_1 e_1_2_9_3_1 e_1_2_9_25_1 e_1_2_9_48_1 e_1_2_9_29_1 |
References_xml | – volume: 34 start-page: 213 year: 2011 end-page: 223 article-title: Type I interferon inhibits interleukin‐1 production and inflammasome activation publication-title: Immunity – volume: 7 start-page: 99 year: 2009 end-page: 109 article-title: Pyroptosis: host cell death and inflammation publication-title: Nat Rev Microbiol – volume: 66 start-page: 1 year: 2015 end-page: 8 article-title: Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and non‐ischemic injury in the mouse publication-title: J Cardiovasc Pharmacol – volume: 24 start-page: 353 year: 2006 end-page: 389 article-title: Genetic analysis of host resistance: toll‐like receptor signaling and immunity at large publication-title: Annu Rev Immunol – volume: 21 start-page: 677 year: 2015 end-page: 687 article-title: Inflammasomes: mechanism of action, role in disease, and therapeutics publication-title: Nat Med – volume: 493 start-page: 674 year: 2013 end-page: 678 article-title: NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice publication-title: Nature – volume: 14 start-page: 454 issue: 5 year: 2013 end-page: 460 article-title: Microtubule‐driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome publication-title: Nat Immunol – volume: 187 start-page: 61 year: 2009 end-page: 70 article-title: Glyburide inhibits the Cryopyrin/Nalp3 inflammasome publication-title: J Cell Biol – volume: 8 year: 2018 article-title: Function and biogenesis of lipopolysaccharides publication-title: EcoSal Plus – volume: 451 start-page: 427 issue: 3 year: 2013 end-page: 437 article-title: The anti‐inflammatory drug BAY 11–7082 suppresses the MyD88‐dependent signalling network by targeting the ubiquitin system publication-title: Biochemical J – volume: 187 start-page: 6143 year: 2011 end-page: 6156 article-title: Inflammasome activation of IL‐18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus publication-title: J Immun – volume: 78 start-page: A70 year: 2019 end-page: A71 article-title: P160 The first phase 2A proof‐of‐concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout publication-title: Ann Rheum Dis – volume: 5 start-page: 316 year: 2014 article-title: A comparative review of toll‐like receptor 4 expression and functionality in different animal species publication-title: Front Immunol – volume: 95 start-page: 149 year: 2015 end-page: 178 article-title: NOD‐like receptors: versatile cytosolic sentinels publication-title: Physiol Rev – volume: 38 start-page: 27 issue: 1 year: 2018 article-title: Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell‐free system publication-title: Inflamm Regen – volume: 21 start-page: 263 year: 2015 end-page: 269 article-title: The ketone metabolite β‐hydroxybutyrate blocks NLRP3 inflammasome–mediated inflammatory disease publication-title: Nat Med – volume: 17 start-page: 694 year: 2018 end-page: 702 article-title: NLRP3: a promising therapeutic target for autoimmune diseases publication-title: Autoimmun Rev – volume: 16 start-page: 81 year: 2019 article-title: A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury publication-title: J Neuroinflammation – volume: 154 start-page: 551 year: 2010 end-page: 554 article-title: Pathogen‐associated molecular pattern‐triggered immunity: veni, vidi…? publication-title: Plant Physiol – volume: 97 start-page: 825 issue: 5 year: 2015 end-page: 835 article-title: Syk is involved in NLRP3 inflammasome‐mediated caspase‐1 activation through adaptor ASC phosphorylation and enhanced oligomerization publication-title: J Leukoc Biol – volume: 15 start-page: 556 issue: 6 year: 2019 end-page: 559 article-title: MCC950 directly targets the NLRP3 ATP‐hydrolysis motif for inflammasome inhibition publication-title: Nat Chem Bio – volume: 20 start-page: 1289 issue: 12 year: 2010 end-page: 1305 article-title: Chemical probing reveals insights into the signaling mechanism of inflammasome activation publication-title: Cell Res – volume: 160 start-page: 62 year: 2015 end-page: 73 article-title: Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome publication-title: Cell – volume: 63 start-page: 316 year: 2014 end-page: 322 article-title: A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury following ischemia‐reperfusion in the mouse publication-title: J Cardiovasc Pharmacol – volume: 37 start-page: 284 year: 2013 end-page: 291 article-title: Pattern recognition receptors in innate immunity, host defense, and immunopathology publication-title: Adv Physiol Educ – volume: 18 start-page: e27 year: 2018 article-title: Damage‐associated molecular patterns in inflammatory diseases publication-title: Immune Netw – volume: 284 start-page: 24192 year: 2009 end-page: 24203 article-title: MyD88 adapter‐like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2‐and TLR4‐mediated NF‐κB proinflammatory responses publication-title: J Biol Chem – volume: 306 start-page: 1186 year: 2004 end-page: 1188 article-title: Microbial factor‐mediated development in a host‐bacterial mutualism publication-title: Science – volume: 44 start-page: 833 issue: 4 year: 2016 end-page: 846 article-title: Human monocytes engage an alternative inflammasome pathway publication-title: Immunity – volume: 104 start-page: 8041 year: 2007 end-page: 8046 article-title: Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling publication-title: Proc Natl Acad Sci USA – volume: 179 start-page: 4083 year: 2007 end-page: 4092 article-title: Role for MyD88‐independent, TRIF pathway in lipid A/TLR4‐induced endotoxin tolerance publication-title: J Immunol – volume: 6 start-page: 973 year: 2005 end-page: 979 article-title: Are innate immune signaling pathways in plants and animals conserved? publication-title: Nat Immunol – volume: 72 start-page: 217 year: 2020 end-page: 224 article-title: Differential expression of the inflammasome complex genes in systemic lupus erythematosus publication-title: Immunogenetics – volume: 81 start-page: 1 year: 2007 end-page: 5 article-title: DAMPs, PAMPs and alarmins: all we need to know about danger publication-title: J Leukoc Biol – volume: 85 start-page: 1504 year: 2013 end-page: 1512 article-title: A novel benzo [d] imidazole derivate prevents the development of dextran sulfate sodium‐induced murine experimental colitis via inhibition of NLRP3 inflammasome publication-title: Biochem Pharmacol – volume: 249 start-page: 158 year: 2012 end-page: 175 article-title: PAMP s and DAMP s: signal 0s that spur autophagy and immunity publication-title: Immunol Rev – volume: 301 start-page: 640 year: 2003 end-page: 643 article-title: Role of adaptor TRIF in the MyD88‐independent toll‐like receptor signaling pathway publication-title: Science – volume: 13 start-page: 255 issue: 3 year: 2012 end-page: 263 article-title: Activation of autophagy by inflammatory signals limits IL‐1β production by targeting ubiquitinated inflammasomes for destruction publication-title: Nat Immunol – volume: 36 start-page: 728 year: 2007 end-page: 736 article-title: Parthenolide inhibits IκB kinase, NF‐κB activation, and inflammatory response in cystic fibrosis cells and mice publication-title: Am J Respir Cell Mol Biol – volume: 6 start-page: 262 year: 2015 article-title: NLRP3 inflammasome and its inhibitors: a review publication-title: Front Pharmacol – volume: 526 start-page: 660 year: 2015 end-page: 665 article-title: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death publication-title: Nature – volume: 117 start-page: 960 issue: 3 year: 2011 end-page: 970 article-title: Tumor suppressor death‐associated protein kinase is required for full IL‐1β production publication-title: Am J Hematol – start-page: 4 year: 1996 end-page: 5 – volume: 49 start-page: 331 year: 2013 end-page: 338 article-title: Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity publication-title: Mol Cell – volume: 22 start-page: 240 year: 2009 end-page: 273 article-title: Pathogen recognition and inflammatory signaling in innate immune defenses publication-title: Clin Microbiol Rev – volume: 71 start-page: 635 year: 2002 end-page: 700 article-title: Lipopolysaccharide endotoxins publication-title: Annu Rev Biochem – start-page: 1055 year: 2016 end-page: 1069 – volume: 285 start-page: 9792 issue: 13 year: 2010 end-page: 9802 article-title: Anti‐inflammatory compounds parthenolide and Bay 11–7082 are direct inhibitors of the inflammasome publication-title: J Biol Chem – volume: 492 start-page: 123 issue: 7427 year: 2012 end-page: 127 article-title: The calcium‐sensing receptor regulates the NLRP3 inflammasome through Ca 2+ and cAMP publication-title: Nature – volume: 45 start-page: e66 year: 2013 article-title: Recognition of lipopolysaccharide pattern by TLR4 complexes publication-title: Exp Mol Med – volume: 240 start-page: 419 issue: 2 year: 1997 end-page: 424 article-title: Nitric oxide reversibly inhibits seven members of the caspase family via S‐nitrosylation publication-title: Biochem Biophys Res Commun – volume: 211 start-page: 1333 issue: 7 year: 2014 end-page: 1347 article-title: The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation publication-title: J Exp Med – volume: 13 start-page: 453 issue: 6 year: 2013 end-page: 460 article-title: The history of toll‐like receptors — redefining innate immunity publication-title: Nat Rev Immunol – volume: 8 start-page: 36 year: 2017 article-title: Canonical and non‐canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation publication-title: Front Immunol – volume: 12 year: 2016 article-title: Immune sensing of lipopolysaccharide in plants and animals: same but different publication-title: PLoS Pathog – volume: 14 start-page: 65 issue: 1 year: 2017 end-page: 79 article-title: Post‐translational regulation of inflammasomes publication-title: Cell Mol Immunol – volume: 293 start-page: 15195 year: 2018 end-page: 15207 article-title: Interleukin‐1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and toll‐like receptor signaling publication-title: J Biol Chem – volume: 113 start-page: 153 year: 2004 end-page: 162 article-title: Signal transduction by the lipopolysaccharide receptor, toll‐like receptor‐4 publication-title: Immunology – volume: 190 start-page: 307 year: 2013 end-page: 316 article-title: Complete dependence on IRAK4 kinase activity in TLR2, but Not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to streptococcus pneumoniae infection in IRAK4 kinase‐inactive mice publication-title: J Immun – volume: 299 start-page: 187 year: 2001 end-page: 197 article-title: Identification and characterization of a novel class of interleukin‐1 post‐translational processing inhibitors publication-title: J Pharmacol Exp Ther – volume: 17 start-page: 250 issue: 3 year: 2016 end-page: 258 article-title: NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component publication-title: Nat Immunol – volume: 74 start-page: 355 year: 2005 end-page: 383 article-title: NOD‐LRR proteins: role in host‐microbial interactions and inflammatory disease publication-title: Annu Rev Biochem – year: 2015 – volume: 1787 start-page: 1352 issue: 11 year: 2009 end-page: 1362 article-title: SR/ER–mitochondrial local communication: calcium and ROS publication-title: Biochim Biophys Acta Bioenerg – volume: 8 start-page: 1518 year: 2017 article-title: Isoliquiritigenin activates nuclear factor erythroid‐2 related factor 2 to suppress the NOD‐like receptor protein 3 inflammasome and inhibits the NF‐κB pathway in macrophages and in acute lung injury publication-title: Front Immunol – volume: 287 start-page: 41732 year: 2012 end-page: 41743 article-title: Multiple binding sites on the pyrin domain of ASC protein allow self‐association and interaction with NLRP3 protein publication-title: J Biol Chem – volume: 280 start-page: 2830 issue: 12 year: 2013 end-page: 2841 article-title: The anti‐inflammatory compound BAY‐11‐7082 is a potent inhibitor of protein tyrosine phosphatases publication-title: FEBS J – volume: 530 start-page: 354 issue: 7590 year: 2016 end-page: 357 article-title: NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux publication-title: Nature – volume: 291 start-page: C1082 issue: 5 year: 2006 end-page: C1088 article-title: Mitochondrial reactive oxygen species and Ca2+ signaling publication-title: Am J Physiol Cell Physiol – volume: 21 start-page: 248 year: 2015 end-page: 255 article-title: A small‐molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases publication-title: Nat Med – volume: 5 issue: 8 year: 2009 article-title: Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases publication-title: PLoS Pathog – volume: 214 start-page: 3219 year: 2017 end-page: 3238 article-title: Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders publication-title: J Exp Med – volume: 76 start-page: 100924 year: 2020 article-title: An overview of the non‐canonical inflammasome publication-title: Mol Aspects Med – volume: 124 start-page: 901 year: 2017 end-page: 905 article-title: Epidemiology of Parkinson's disease publication-title: J Neural Transm – start-page: 175 year: 2018 end-page: 187 – volume: 10 start-page: 826 year: 2010 end-page: 837 article-title: Sterile inflammation: sensing and reacting to damage publication-title: Nat Rev Immunol – volume: 1 start-page: 319 year: 1998 end-page: 325 article-title: Autoproteolytic activation of pro‐caspases by oligomerization publication-title: Mol Cell – volume: 25 start-page: 5533 issue: 23 year: 2021 article-title: Inhibiting the NLRP3 inflammasome publication-title: Molecules – volume: 289 start-page: 1142 year: 2014 end-page: 1150 article-title: 3, 4‐methylenedioxy‐β‐nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome publication-title: J Biol Chem – volume: 30 start-page: 16 year: 2011 end-page: 34 article-title: Pathogen recognition by the innate immune system publication-title: Int Rev Immunol – volume: 183 start-page: 787 year: 2009 end-page: 791 article-title: Cutting edge: NF‐κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression publication-title: J Immun – volume: 21 start-page: 317 year: 2009 end-page: 337 article-title: The roles of TLRs, RLRs and NLRs in pathogen recognition publication-title: Int Immunol – volume: 10 start-page: 417 year: 2002 end-page: 426 article-title: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL‐β publication-title: Mol Cell – volume: 285 start-page: 9792 year: 2010 end-page: 9802 article-title: Anti‐inflammatory compounds parthenolide and Bay 11–7082 are direct inhibitors of the inflammasome publication-title: J Biol Chem – volume: 45 start-page: 2918 issue: 10 year: 2015 end-page: 2926 article-title: NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 publication-title: Eur J Immunol – year: 2020 – volume: 291 start-page: 103 issue: 1 year: 2016 end-page: 109 article-title: A genome‐wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation publication-title: J Biol Chem – volume: 41 start-page: 273 year: 2016 end-page: 279 article-title: NF‐κB activation via MyD88‐dependent toll‐like receptor signaling is inhibited by trichothecene mycotoxin deoxynivalenol publication-title: J Toxicol Sci – volume: 469 start-page: 221 issue: 7329 year: 2011 end-page: 225 article-title: A role for mitochondria in NLRP3 inflammasome activation publication-title: Nature – volume: 282 start-page: 15319 year: 2007 end-page: 15323 article-title: Toll‐like receptors and type I interferons publication-title: J Biol Chem – volume: 140 start-page: 821 year: 2010 end-page: 832 article-title: The inflammasomes publication-title: Cell – volume: 10 start-page: 2538 year: 2019 article-title: Pharmacological inhibitors of the NLRP3 inflammasome publication-title: Front Immunol – volume: 9 start-page: 465 year: 2009 end-page: 479 article-title: Signalling through C‐type lectin receptors: shaping immune responses publication-title: Nat Rev Immunol – volume: 148 start-page: 487 issue: 3 year: 2010 end-page: 490 article-title: IKK inhibitor bay 11–7082 induces necroptotic cell death in precursor‐B acute lymphoblastic leukaemic blasts publication-title: Br J Haematol – volume: 157 start-page: 105637 year: 2021 article-title: Inhibition of NLRP3‐inflammasome mediated IL‐1β release by phenylpropanoic acid derivatives: in‐silico and in‐vitro approach publication-title: Eur J Pharm Sci – volume: 42 start-page: 145 year: 2008 end-page: 151 article-title: LPS/TLR4 signal transduction pathway publication-title: Cytokine – volume: 46 start-page: 815 issue: 6 year: 2012 end-page: 822 article-title: Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation publication-title: Am J Respir Cell Mol Biol – ident: e_1_2_9_65_1 doi: 10.1038/nature09663 – ident: e_1_2_9_73_1 doi: 10.4049/jimmunol.1101284 – ident: e_1_2_9_5_1 doi: 10.1111/j.1600-065X.2012.01146.x – ident: e_1_2_9_46_1 doi: 10.1038/cmi.2016.29 – ident: e_1_2_9_98_1 doi: 10.1074/jbc.M113.515080 – ident: e_1_2_9_22_1 doi: 10.1146/annurev.biochem.71.110601.135414 – ident: e_1_2_9_83_1 doi: 10.1097/FJC.0000000000000053 – ident: e_1_2_9_24_1 doi: 10.1038/nri3446 – ident: e_1_2_9_86_1 doi: 10.1111/febs.12283 – ident: e_1_2_9_41_1 doi: 10.1016/j.cell.2010.01.040 – ident: e_1_2_9_81_1 doi: 10.3389/fimmu.2019.02538 – ident: e_1_2_9_95_1 doi: 10.1186/s12974-019-1471-y – ident: e_1_2_9_47_1 doi: 10.1189/jlb.3HI0814-371RR – ident: e_1_2_9_89_1 doi: 10.1038/nm.3804 – ident: e_1_2_9_26_1 doi: 10.1016/j.cyto.2008.01.006 – ident: e_1_2_9_25_1 doi: 10.3389/fimmu.2014.00316 – ident: e_1_2_9_61_1 doi: 10.1016/j.immuni.2016.01.012 – ident: e_1_2_9_82_1 doi: 10.3390/molecules25235533 – ident: e_1_2_9_62_1 doi: 10.1038/nature11588 – ident: e_1_2_9_67_1 doi: 10.1002/eji.201545655 – ident: e_1_2_9_27_1 doi: 10.1111/j.1365-2567.2004.01976.x – ident: e_1_2_9_19_1 doi: 10.4110/in.2018.18.e27 – ident: e_1_2_9_79_1 – ident: e_1_2_9_16_1 doi: 10.1152/advan.00058.2013 – ident: e_1_2_9_11_1 doi: 10.1038/nri2569 – ident: e_1_2_9_14_1 doi: 10.1146/annurev.biochem.74.082803.133347 – ident: e_1_2_9_6_1 doi: 10.1038/ni1253 – ident: e_1_2_9_70_1 doi: 10.1038/nature11729 – ident: e_1_2_9_91_1 doi: 10.1016/j.bcp.2013.03.008 – ident: e_1_2_9_48_1 doi: 10.1371/journal.ppat.1000559 – ident: e_1_2_9_18_1 doi: 10.1104/pp.110.161547 – ident: e_1_2_9_64_1 doi: 10.1016/j.bbabio.2009.06.004 – ident: e_1_2_9_97_1 doi: 10.1038/nm.3806 – ident: e_1_2_9_99_1 doi: 10.1074/jbc.M109.082305 – volume: 117 start-page: 960 issue: 3 year: 2011 ident: e_1_2_9_53_1 article-title: Tumor suppressor death‐associated protein kinase is required for full IL‐1β production publication-title: Am J Hematol – ident: e_1_2_9_10_1 doi: 10.1146/annurev.immunol.24.021605.090552 – ident: e_1_2_9_88_1 doi: 10.1042/BJ20121651 – ident: e_1_2_9_38_1 doi: 10.1038/nm.3893 – ident: e_1_2_9_36_1 doi: 10.1152/physrev.00009.2014 – ident: e_1_2_9_75_1 doi: 10.1007/s00251-020-01158-6 – ident: e_1_2_9_31_1 doi: 10.1074/jbc.RA118.003314 – ident: e_1_2_9_49_1 doi: 10.1038/ni.3333 – ident: e_1_2_9_87_1 doi: 10.1111/j.1365-2141.2009.07988.x – ident: e_1_2_9_7_1 doi: 10.1126/science.1102218 – ident: e_1_2_9_54_1 doi: 10.1038/ni.2215 – ident: e_1_2_9_9_1 doi: 10.1038/nri2873 – ident: e_1_2_9_45_1 doi: 10.4049/jimmunol.0901363 – ident: e_1_2_9_43_1 doi: 10.1016/j.molcel.2012.11.009 – ident: e_1_2_9_101_1 doi: 10.1016/j.ejps.2020.105637 – ident: e_1_2_9_30_1 doi: 10.1084/jem.21213insight1 – ident: e_1_2_9_92_1 doi: 10.1083/jcb.200903124 – ident: e_1_2_9_58_1 doi: 10.1016/S1097-2765(00)80032-5 – ident: e_1_2_9_35_1 doi: 10.1074/jbc.R700009200 – volume: 78 start-page: A70 year: 2019 ident: e_1_2_9_78_1 article-title: P160 The first phase 2A proof‐of‐concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile™ (OLT1177™), in acute gout publication-title: Ann Rheum Dis – ident: e_1_2_9_12_1 doi: 10.1093/intimm/dxp017 – ident: e_1_2_9_69_1 doi: 10.1186/s41232-018-0085-6 – ident: e_1_2_9_42_1 doi: 10.1016/j.immuni.2011.02.006 – start-page: 4 volume-title: Immunobiology: The Immune System in Health and Disease year: 1996 ident: e_1_2_9_2_1 – ident: e_1_2_9_51_1 doi: 10.1038/nature16959 – ident: e_1_2_9_71_1 doi: 10.1007/s00702-017-1686-y – ident: e_1_2_9_74_1 doi: 10.1016/j.autrev.2018.01.020 – ident: e_1_2_9_50_1 doi: 10.1074/jbc.C115.700492 – volume: 299 start-page: 187 year: 2001 ident: e_1_2_9_93_1 article-title: Identification and characterization of a novel class of interleukin‐1 post‐translational processing inhibitors publication-title: J Pharmacol Exp Ther – ident: e_1_2_9_13_1 doi: 10.1128/CMR.00046-08 – ident: e_1_2_9_44_1 doi: 10.1074/jbc.M112.381228 – ident: e_1_2_9_15_1 doi: 10.3109/08830185.2010.529976 – ident: e_1_2_9_21_1 doi: 10.1128/ecosalplus.ESP-0001-2018 – ident: e_1_2_9_100_1 doi: 10.1165/rcmb.2006-0323OC – ident: e_1_2_9_96_1 doi: 10.1038/s41589-019-0277-7 – ident: e_1_2_9_39_1 doi: 10.3389/fimmu.2017.00036 – ident: e_1_2_9_40_1 doi: 10.1016/S1097-2765(02)00599-3 – ident: e_1_2_9_28_1 doi: 10.4049/jimmunol.179.6.4083 – ident: e_1_2_9_68_1 doi: 10.1016/j.mam.2020.100924 – ident: e_1_2_9_34_1 doi: 10.1074/jbc.M109.023044 – ident: e_1_2_9_55_1 doi: 10.1084/jem.20132486 – ident: e_1_2_9_76_1 – ident: e_1_2_9_3_1 doi: 10.3389/fphar.2015.00262 – ident: e_1_2_9_4_1 doi: 10.1189/jlb.0306164 – ident: e_1_2_9_29_1 doi: 10.1126/science.1087262 – ident: e_1_2_9_8_1 doi: 10.1007/978-3-7643-8550-7_35 – ident: e_1_2_9_60_1 doi: 10.1038/nrmicro2070 – ident: e_1_2_9_20_1 doi: 10.1371/journal.ppat.1005596 – ident: e_1_2_9_17_1 doi: 10.1016/B978-0-12-805417-8.00014-7 – ident: e_1_2_9_77_1 – ident: e_1_2_9_84_1 doi: 10.1097/FJC.0000000000000247 – ident: e_1_2_9_59_1 doi: 10.1038/nature15514 – ident: e_1_2_9_52_1 doi: 10.1038/cr.2010.135 – ident: e_1_2_9_37_1 doi: 10.1073/pnas.0611496104 – ident: e_1_2_9_66_1 doi: 10.1038/ni.2550 – ident: e_1_2_9_57_1 doi: 10.1165/rcmb.2011-0135OC – ident: e_1_2_9_56_1 doi: 10.1006/bbrc.1997.7672 – ident: e_1_2_9_32_1 doi: 10.4049/jimmunol.1201644 – ident: e_1_2_9_94_1 doi: 10.3389/fimmu.2017.01518 – ident: e_1_2_9_23_1 doi: 10.1038/emm.2013.97 – ident: e_1_2_9_33_1 doi: 10.2131/jts.41.273 – ident: e_1_2_9_63_1 doi: 10.1152/ajpcell.00217.2006 – ident: e_1_2_9_85_1 doi: 10.1074/jbc.M109.082305 – ident: e_1_2_9_72_1 doi: 10.1016/j.cell.2014.11.047 – ident: e_1_2_9_80_1 – ident: e_1_2_9_90_1 doi: 10.1084/jem.20171419 |
SSID | ssj0013273 |
Score | 2.4933043 |
SecondaryResourceType | review_article |
Snippet | Cells encounter continuous challenges due to tissue insult caused by endogenous and/or exogenous stimuli. Among the mechanisms set in place to counterbalance... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e13124 |
SubjectTerms | Alarmins - metabolism Caspase Caspase 1 - immunology Cell death Cell Membrane - metabolism Cell membranes Enzyme Inhibitors - pharmacology Humans Immunity, Innate - immunology inflammasome inhibitors Inflammasomes Inflammation Innate immunity Interleukin-18 - metabolism Interleukin-1beta - metabolism Intracellular Signaling Peptides and Proteins - immunology Intracellular signalling NLR Family, Pyrin Domain-Containing 3 Protein - antagonists & inhibitors NLR Family, Pyrin Domain-Containing 3 Protein - metabolism NLRP3 inflammasome Pathogen-Associated Molecular Pattern Molecules - metabolism Phosphate-Binding Proteins - immunology Proteolysis Pyroptosis Pyroptosis - immunology Signal transduction Signal Transduction - immunology Toll-Like Receptors - metabolism |
Title | Reviewing the importance of TLR‐NLRP3‐pyroptosis pathway and mechanism of experimental NLRP3 inflammasome inhibitors |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fsji.13124 https://www.ncbi.nlm.nih.gov/pubmed/34861056 https://www.proquest.com/docview/2620434608 https://www.proquest.com/docview/2606925102 |
Volume | 95 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRSAuPAqUhVIZxIFLVk5s5yFOLbAqVVuhpZV6QIrs2BYBkqyaXcFy4ifwG_kljJ1kteUhIU6JlHHseGbsz5kXwNOYJ5bqSASFNAUeUDIWpDHXAbPIYyWVCBMXO3x8Eh-c8cNzcb4Bz4dYmC4_xOqHm9MMv147BZeqXVPy9kM5DhluT7j-Ol8tB4im0ZoFobMuM0qDjCeizyrkvHhWLS_vRb8BzMt41W84k5vwbhhq52fycbyYq3Hx9Zcsjv_5LbfgRg9EyV4nObdhw9RbcLUrTbncgmvHvdH9Dnzp7Ae4xxFEi6SsPGRHYSGNJadH0x_fvp8cTd8wvM6WF81s3rRlS1yp489ySWStSWVcfHHZVq7Fek0B4hsSlHIUzEq2TYXvr9-XqnRFgO7C2eTV6YuDoC_YEBRccB4kKbcyCqXgUsUqYVKEBuFBZjlTVPNIJ1ZLhJRFQRPEpZRaZTIrOEtTZhOq2T3YrJva3AeSGisk16lOWIaIT0mqQ2syzoyLGwzpCJ4NrMuLPpu5K6rxKR9ONTinuZ_TETxZkc66FB5_ItoZ-J_3WtzmPlk_4zFNR_B49Rj1zxlVZG2ahaOhcYYgkUYj2O7kZtUL4ymiUxHjYD33_959_vbwtb958O-kD-F65GIxvAv5DmzOLxbmESKkudqFK3v7L_cnu14lfgJSlA9Q |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4ti3hceCwLFBYwiAOXVE5s5yFxQYhVd2krVLrSXlBkJ7YI0KTatIJy4ifwG_kljJ2HujwkxCmRMo4deybzjcczA_A05JGheSC8TOoMDZSEeXHIc48ZXGMllfAjGzs8mYajE358Kk534HkXC9Pkh-g33KxkuP-1FXC7Ib0l5fWHYugz1E8X4KKt6O0Mqlmw5UNo_MuMUi_hkWjzCtlzPH3T89roN4h5HrE6lXN4Hd51g21OmnwcrldqmH39JY_j_37NDbjWYlHyomGem7Cjyz241FSn3OzB5Unrd78FXxoXAqo5goCRFAuH2pFfSGXIfDz78e37dDx7w_C63JxVy1VVFzWx1Y4_yw2RZU4W2oYYF_XCttguK0BcQ4KMjry5kHW1wPeX7wtV2DpA-3By-Gr-cuS1NRu8jAvOvSjmRga-FFyqUEVMCl8jQkgMZ4rmPMgjk0tElVlGI4SmlBqlEyM4i2NmIpqz27BbVqW-CyTWRkiex3nEEgR9StLcNzrhTNvQQZ8O4Fm3dmnWJjS3dTU-pZ1hg3OaujkdwJOedNlk8fgT0UHHAGkryHXq8vUzHtJ4AI_7xyiC1q8iS12tLQ0NE8SJNBjAnYZx-l4YjxGgihAH65b_792nb4-P3M29fyd9BFdG88k4HR9NX9-Hq4ENzXAnyg9gd3W21g8QMK3UQycXPwGkeRH5 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIiouPMproYBBHLhk5cTOS5wQZdWW7apaWqkHpMiObZGWJKtmV7Cc-An8Rn4JYycbbXlIiFMiZRw7npnMZ49nBuBFxGNDVRB6udA5LlBS5iURVx4zyGMpZOjHNnb4cBLtnfCD0_B0A16tYmHa_BD9hpvVDPe_tgo-U2ZNyZuzYugzNE9X4CqPaGJFencarLkQWvcyo9RLeRx2aYXsMZ6-6WVj9BvCvAxYncUZ3YQPq7G2B03Oh4u5HOZff0nj-J8fcwtudEiUvG5F5zZs6GobrrW1KZfbsHXYed3vwJfWgYBGjiBcJEXpMDtKC6kNOR5Pf3z7PhlPjxheZ8uLejavm6IhttbxZ7EkolKk1DbAuGhK22K9qABxDQmKOUpmKZq6xPdXHwtZ2CpAd-Fk9Pb4zZ7XVWzwch5y7sUJNyLwRciFjGTMROhrxAep4UxSxQMVGyUQU-Y5jRGYUmqkTk3IWZIwE1PF7sFmVVf6AZBEm1BwlaiYpQj5pKDKNzrlTNvAQZ8O4OWKdVnepTO3VTU-ZatlDc5p5uZ0AM970lmbw-NPRDsr_medGjeZy9bPrHQN4Fn_GBXQelVEpeuFpaFRiiiRBgO438pN3wvjCcLTMMLBOu7_vfvs_cG-u3n476RPYetod5SN9yfvHsH1wMZluOPkO7A5v1jox4iW5vKJ04qfhV4QsQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reviewing+the+importance+of+TLR-NLRP3-pyroptosis+pathway+and+mechanism+of+experimental+NLRP3+inflammasome+inhibitors&rft.jtitle=Scandinavian+journal+of+immunology&rft.au=Kinra%2C+Manas&rft.au=Nampoothiri%2C+Madhavan&rft.au=Arora%2C+Devinder&rft.au=Mudgal%2C+Jayesh&rft.date=2022-02-01&rft.eissn=1365-3083&rft.volume=95&rft.issue=2&rft.spage=e13124&rft_id=info:doi/10.1111%2Fsji.13124&rft_id=info%3Apmid%2F34861056&rft.externalDocID=34861056 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0300-9475&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0300-9475&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0300-9475&client=summon |